Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
QUINLAN KEVIN W
Chief Financial Officer at Anika Therapeutics. Filing since 10 Mar 2008.
CIK 0001209114
Company
Date
Role
Action
Shares
Amount
Of holding
ANIK
Anika Therapeutics, Inc.
27 Mar 2013
Chief Financial Officer
Sold, plan not stated
18,374
$206.52K
40.4%
ANIK
Anika Therapeutics, Inc.
22 Mar 2013
Chief Financial Officer
Sold, plan not stated
31,626
$355.48K
53.8%
ANIK
Anika Therapeutics, Inc.
21 Mar 2013
Chief Financial Officer
Sold, plan not stated
25,000
$281.00K
48.0%
ANIK
Anika Therapeutics, Inc.
23 Aug 2010
Chief Financial Officer
Bought
4,000
$20.00K
34.1%
ANIK
Anika Therapeutics, Inc.
7 Nov 2008
Chief Financial Officer
Bought
1,000
$5.20K
25.0%
ANIK
Anika Therapeutics, Inc.
6 Nov 2008
Chief Financial Officer
Bought
1,000
$5.34K
33.3%
ANIK
Anika Therapeutics, Inc.
19 Mar 2008
Chief Financial Officer
Bought
2,000
$16.58K
200%
ANIK
Anika Therapeutics, Inc.
10 Mar 2008
Chief Financial Officer
Bought
1,000
$9.88K
opened
8 decisions on file.
